William J. DeLaney III - Aug 19, 2024 Form 4 Insider Report for Cigna Group (CI)

Role
Director
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Aug 19, 2024
Transactions value $
-$450,974
Form type
4
Date filed
8/21/2024, 05:14 PM
Previous filing
Jul 2, 2024
Next filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $471K +2.69K +15.34% $175.09 20.2K Aug 19, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$922K -2.69K -13.3% $342.68 17.5K Aug 19, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -2.69K -100% $0.00 0 Aug 19, 2024 Common Stock, $.01 Par Value 2.69K $175.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.
F2 These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.